BEUDAMED
    FDA Adverse Event Injury Summary report: N

    G7 SCREW 6.5MM X 30MM

    MDR report key: 19528604 · Received June 13, 2024

    Report

    Report Number
    0001825034-2024-01577
    Event Type
    Injury
    Date Received
    June 13, 2024
    Date of Event
    May 3, 2024
    Report Date
    June 21, 2024
    Manufacturer
    ZIMMER BIOMET, INC.
    Product Code
    PBI
    UDI-DI
    00880304527478
    PMA / PMN Number
    K121874
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    CA, US
    Reporter Occupation
    PHYSICIAN
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    (B)(4). B2: IT WAS REPORTED THAT BETWEEN (B)(6) 2024, THAT THE PATIENT EXPIRED AFTER BEING WEANED OFF THE VENTILATOR. THE EXACT DATE IS UNKNOWN. D10: 11-107018, FREEDOM CONSTR HD 36MM T1 STD, (B)(6). 150464, OSS 3CM DIAPHYSEL SEGMENT, (B)(6). 150368, OSS CEMENTED IM STEM 14X150, (B)(6). 30203606, LINER CONSTRAINED NEUTRAL 36 MM, (B)(6). CUSTOMER HAS INDICATED THAT THE PRODUCT WILL NOT BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED.

    Additional Manufacturer Narrative · 0

    THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL AND/OR CORRECTED INFORMATION. UPDATED: D4, G3, G6, H2, H3, H4, H6. IT WAS REPORTED AN ELDERLY PATIENT WITH A SIGNIFICANT CARDIAC HISTORY OF CORONARY ARTERY DISEASE, HYPERTENSION, HEART FAILURE, QUADRUPLE BYPASS, CARDIAC STENTS, AND PROXIMAL ATRIAL FIBRILLATION, UNDERWENT A REVISION DUE TO FEMORAL LOOSENING AND SIGNIFICANT BONE LOSS. THE PATIENT WAS PRESCRIBED AND TAKING ELIQUIS FOR THE CHRONIC CARDIAC CONDITIONS AND THE THERAPY WAS HELD FOUR DAYS PRIOR TO THE REVISION. DURING THE PROCEDURE, THE PATIENT HAD A TOTAL BLOOD LOSS OF 600ML OF BLOOD LOSS AND RECEIVED TWO UNITS OF RBCS. ONE DAY POST-OPERATIVELY, THE PATIENT DISPLAYED WORSENING DYSARTHRIA AND RADIOGRAPHIC IMAGING CONFIRMED A CEREBELLAR STROKE HAD OCCURRED. AFTER THE EVENT, THE PATIENT REMAINED NPO UNTIL A SWALLOW STUDY WAS PERFORMED AND SUBSEQUENTLY, DURING THE SWALLOW STUDY, THE PATIENT EXPERIENCED AN EPISODE OF COUGHING AND BECAME UNRESPONSIVE WHICH LED TO CARDIAC ARREST. THE PATIENT UNDERWENT THREE ROUNDS OF CPR AND INTUBATED AND ROSC WAS ACHIEVED. THE PATIENT WAS TRANSFERRED TO MICU AND THE MRI DISPLAYED A SHOWER OF EMBOLIC STROKES. ONE-WEEK POST-OPERATIVE, NEUROLOGY NOTED THAT THE PATIENT WAS OFF SEDATION, MAINTAINED VENTILATION, AND WAS ABLE TO FOLLOW COMMANDS. THE PATIENT WAS DIAGNOSED WITH ASPIRATION PNEUMONIA AND AFTER MORE THAN 17 DAYS HOSPITALIZED AND A COURSE OF BEING WEANED OFF THE VENTILATOR, THE PATIENT EXPIRED. THE HUMAN BODY CONSISTS OF 4-5 LITERS OF BLOOD. ANY TYPE OF BLOOD LOSS HAS THE POTENTIAL TO CAUSE A COMPLICATION; HOWEVER, IT IS USUALLY THE LARGE, RAPID BLOOD LOSS DURING SURGERY OR A TRAUMA THAT WILL MOST LIKELY CAUSE COMPLICATIONS. THE AMOUNT OF BLOOD LOSS THAT MAY LEAD TO INTRA AND/OR POSTOPERATIVE COMPLICATIONS DEPENDS ON THE INDIVIDUAL PERSON AND COMORBIDITIES, SUCH AS BODY MASS INDEX, GENDER, PRE-OPERATIVE HEMOGLOBIN LEVEL, MEDICATIONS, AND/OR THE PRESENCE OF CERTAIN HEALTH CONDITIONS, AS WELL AS DURATION OF SURGERY. THE ANESTHESIA PROVIDER DURING THE SURGERY MAINTAINS HEMODYNAMIC AND FLUID VOLUME LEVELS TO ENSURE NO FURTHER COMPLICATIONS FROM BLOOD LOSS ARISES. BLOOD LOSS EFFECTS ARE BASED ON INDIVIDUAL FACTORS, TREATMENT DEPENDS ON THE AMOUNT OF BLOOD LOSS, HOW QUICKLY IT WAS LOST, AND THE INDIVIDUALS HEALTH STATE. AS THE COMPLAINT STATES, THE INDIVIDUAL LOST 600ML OF BLOOD AND DUE TO THE PATIENT'S COMORBID STATE, REQUIRED INTERVENTION. PROCEDURAL RELATED COMPLICATIONS ARE INFLUENCED BY THE TYPE OF SURGERY, PATIENTS PRE-EXISTING COMORBIDITIES, AND PERIOPERATIVE MANAGEMENT. A STROKE CAN HAPPEN TO ANYONE AT ANY TIME. IT OCCURS WHEN BLOOD FLOW TO AN AREA OF BRAIN IS CUT OFF. WHEN THIS HAPPENS, BRAIN CELLS ARE DEPRIVED OF OXYGEN AND BEGIN TO DIE. AN ISCHEMIC STROKE OCCURS WHEN A BLOOD VESSEL CARRYING BLOOD TO THE BRAIN IS BLOCKED BY A BLOOD CLOT WHICH CAN BE CARDIOGENIC DUE TO UNDERLYING ATRIAL FIBRILLATION OR FROM ANTI- OR HYPERCOAGULANTS WHICH CHANGE THE VISCOSITY OF THE BLOOD. A PERIOPERATIVE STROKE IS A SERIOUS AND RARE COMPLICATION THAT MAY OCCUR WHEN A PATIENT UNDERGOES A SURGICAL PROCEDURE AND, IN THIS CASE, LED TO ASPIRATION WITH A CHOKING EPISODE THAT INTERRUPTED THE PATIENT¿S BREATHING AND RESULTED IN CARDIAC ARREST. THE RECENT STROKE, ASPIRATION, AND CARDIAC ARREST RESULTED IN THE PATIENT BEING ON A VENTILATOR AND DEVELOPING ASPIRATION PNEUMONIA. IT CAN BE DETERMINED THAT THE PATIENT¿S COMORBID STATE AND SERIES OF LIFE-THREATENING EVENTS, CONTRIBUTED TO THE PATIENT'S DEATH. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL REPORT WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

    Description of Event or Problem · 0

    IT WAS REPORTED AN EIGHTY-YEAR-OLD PATIENT WITH A SIGNIFICANT CARDIAC HISTORY HAD A RIGHT TOTAL HIP ARTHROPLASTY WITH COMPETITOR PRODUCT AND, UNDERWENT A REVISION DUE TO FEMORAL LOOSENING AND SIGNIFICANT BONE LOSS. DURING THE PROCEDURE THE PATIENT HAD A TOTAL BLOOD LOSS OF 600ML OF BLOOD LOSS AND RECEIVED TWO UNITS OF RBCS. THE ACETABULAR SYSTEM WAS RETAINED, AND THE STEM, HEAD, AND LINER WERE REVISED WITHOUT FURTHER COMPLICATION. THE PATIENT DISPLAYED WORSENING DYSARTHRIA AND A CODE STROKE WAS CALLED. A CT AND MRI WERE PERFORMED, AND A CEREBELLAR STROKE WAS CONFIRMED. THE PATIENT REMAINED NPO UNTIL A SWALLOW STUDY WAS PERFORMED. DURING THE SWALLOW STUDY, THE PATIENT EXPERIENCED AN EPISODE OF COUGHING AND BECAME UNRESPONSIVE AND WAS FOUND IN CARDIAC ARREST. THE PATIENT UNDERWENT THREE ROUNDS OF CPR AND INTUBATED AND ROSC WAS ACHIEVED. THE PATIENT WAS TRANSFERRED TO MICU AND, THE MRI DISPLAYED A SHOWER OF EMBOLIC STROKES. NEUROLOGY NOTED THAT THE PATIENT WAS OFF SEDATION, MAINTAINED VENTILATION, AND WAS ABLE TO FOLLOW COMMANDS. THE PATIENT WAS DIAGNOSED WITH ASPIRATION PNEUMONIA AND AFTER WEANING OFF THE VENTILATOR, THE PATIENT EXPIRED. ALL IMPLANTS REMAINED IN PLACE AND NO FURTHER INFORMATION HAS BEEN PROVIDED.

    Description of Event or Problem · 0

    NO ADDITIONAL EVENT INFORMATION TO REPORT AT THIS TIME.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    937943 G7 SCREW 6.5MM X 30MM PROSTHESIS, HIPS PBI ZIMMER BIOMET, INC. N/A 7641790 00880304527478

    Patients

    Seq Age Sex Outcome Treatment
    1 80 YR Male Death| R| H SEE H11 NARRATIVE.